TimesSquare Capital Management LLC Has $70.43 Million Stake in Stevanato Group S.p.A. $STVN

TimesSquare Capital Management LLC increased its stake in Stevanato Group S.p.A. (NYSE:STVN) by 7.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 3,500,321 shares of the company’s stock after purchasing an additional 232,645 shares during the quarter. TimesSquare Capital Management LLC owned approximately 1.16% of Stevanato Group worth $70,426,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Thrivent Financial for Lutherans lifted its holdings in Stevanato Group by 7.1% in the 3rd quarter. Thrivent Financial for Lutherans now owns 2,372,390 shares of the company’s stock worth $61,089,000 after purchasing an additional 156,733 shares during the last quarter. Bamco Inc. NY lifted its holdings in Stevanato Group by 4.5% in the 3rd quarter. Bamco Inc. NY now owns 1,973,759 shares of the company’s stock worth $50,824,000 after purchasing an additional 85,709 shares during the last quarter. Jennison Associates LLC lifted its holdings in Stevanato Group by 13.7% in the 4th quarter. Jennison Associates LLC now owns 1,772,896 shares of the company’s stock worth $35,671,000 after purchasing an additional 213,602 shares during the last quarter. ArrowMark Colorado Holdings LLC lifted its holdings in Stevanato Group by 6.7% in the 3rd quarter. ArrowMark Colorado Holdings LLC now owns 1,392,581 shares of the company’s stock worth $35,859,000 after purchasing an additional 86,971 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its holdings in Stevanato Group by 14.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 708,821 shares of the company’s stock worth $17,316,000 after purchasing an additional 87,942 shares during the last quarter.

Stevanato Group Stock Performance

Shares of NYSE STVN opened at €17.80 on Tuesday. The company has a quick ratio of 1.11, a current ratio of 1.63 and a debt-to-equity ratio of 0.21. The business’s 50 day moving average is €15.49 and its two-hundred day moving average is €18.34. The company has a market cap of $5.39 billion, a P/E ratio of 30.17, a P/E/G ratio of 1.66 and a beta of 0.75. Stevanato Group S.p.A. has a 12 month low of €12.89 and a 12 month high of €28.00.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing the consensus estimate of €0.12 by (€0.01). The business had revenue of €273.57 million during the quarter. Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.10 earnings per share. On average, equities analysts expect that Stevanato Group S.p.A. will post 0.68 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts recently weighed in on STVN shares. Weiss Ratings lowered Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 11th. Morgan Stanley reduced their target price on Stevanato Group from $24.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, March 6th. KeyCorp reduced their target price on Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, March 5th. Jefferies Financial Group set a $17.50 target price on Stevanato Group in a report on Tuesday, February 10th. Finally, Wall Street Zen lowered Stevanato Group from a “buy” rating to a “hold” rating in a report on Saturday, February 14th. Three equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold”.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.